//
Clinical Risk Factors and Atherosclerotic Plaque Extent to Define Risk for Major Events in Patients Without Obstructive Coronary Artery Disease: The Long-Term Coronary Computed Tomography Angiography CONFIRM Registry
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease
Long-Term Exposure to Fine Particulate Matter and Cardiovascular Disease in China
Prognostic implications of ischemia with nonobstructive coronary arteries (INOCA): Understanding risks for improving treatment
The Science Underlying COVID-19: Implications for the Cardiovascular System
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events
Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study